Optimizing the concentration of a cancer-treating drug (bleomycin) in patients undergoing electrochemotherapy
Not Applicable
Completed
- Conditions
- Basal cell carcinoma, squamous cell carcinoma, melanoma or metastases of adenocarcinoma of the breast, treated with electrochemotherapyCancerMalignant neoplasm of breast
- Registration Number
- ISRCTN74054653
- Lead Sponsor
- Department of Otorhinolaryngology and Cervicofacial Surgery University Medical Centre
- Brief Summary
2021 Results article in https://doi.org/10.3390/pharmaceutics13091324 (added 26/08/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
1. Eligible for electrochemotherapy of cutaneous tumors (basal cell carcinoma, squamous cell carcinoma, melanoma) and cutaneus metastases of melanoma and adenocarcinoma of the breast
2. Age =18 years
3. Agree to participate in this study and signed informed consent
Exclusion Criteria
1. Do not comply with requirements for the blood collection, or samples were not collected according to the SOP for blood collection
2. Do not comply with the requirements for tumor biopsy, or samples were not collected according to the SOP for tissue sampling
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method